Sleep problems and daytime fatigue in a sample of fibromyalgia patients: a preliminary psychometric evaluation of the Scales for Outcomes in Parkinson’s (SCOPA) Sleep Scale

Le résumé fourni par la source

Objective This study evaluated the psychometric properties of the Scales for Outcomes in Parkinson’s Disease – Sleep Scale (SCOPA-Sleep) in a sample of patients with fibromyalgia syndrome (FMS), and examined the unique and interactive associations between sleep problems, daytime fatigue, and quality of life.Method A total of 79 adults diagnosed with FMS according to the 2010 American College of Rheumatology criteria completed measures assessing sleep problems, daytime fatigue (SCOPA-Sleep), and health-related quality of life (EuroQOL-5D). Exploratory factor analysis (EFA) and internal consistency analyses assessed the dimensionality and reliability of the SCOPA-Sleep. Multiple linear regression examined confounding and moderation effects of sleep problems and fatigue on quality of life, controlling for sociodemographic variables.Results EFA supported a two-factor structure of the SCOPA-Sleep reflecting distinct subscales for nighttime sleep problems and daytime fatigue. The subscales were uncorrelated, and both demonstrated strong internal consistency (α = .87 and .84, respectively). Regression analyses revealed that daytime fatigue was not significantly associated with quality of life after adjusting for covariates. However, sleep problems were a significant predictor of reduced quality of life (β = – .33, p < .01). No significant interaction between sleep problems and fatigue was observed.Conclusions The SCOPA-Sleep may be a useful brief screening tool for sleep-related impairments in clinical FMS assessment. However, given the relatively small and homogeneous sample (predominantly middle-aged women not currently employed), the generalizability of these findings is limited. Future research should replicate these results in larger and more diverse FMS populations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.